Reduced parenteral glucose supply during neonatal infection attenuates neurological and renal pathology associated with modulation of innate and Th1 immunity
Reduced glucose supply can reduce renal and neuro-inflammation during neonatal infection, thereby protecting brain and kidney health in infected preterm neonates.
Authors
- Per Torp Sangild (ORCID: https://orcid.org/0000-0002-5462-7760)
- Jingren Zhong (ORCID: https://orcid.org/0009-0009-1584-6117)
- Henrik Elvang Jensen (ORCID: https://orcid.org/0000-0001-7277-7829)
- Ole Bæk (ORCID: https://orcid.org/0000-0003-0598-0952)
- Richard Doughty
- Duc Ninh Nguyen (ORCID: https://orcid.org/0000-0002-4997-555X)
- Anders Brunse (ORCID: https://orcid.org/0000-0002-0199-3417)
- Thomas Thymann (ORCID: https://orcid.org/0000-0001-7480-6064)
- Benjamin Meyer Jørgensen
Institutions
- University of Copenhagen (DK)
- Akershus University Hospital (NO)
- Odense University Hospital (DK)
- Copenhagen University Hospital (DK)
Publication Details
- Journal
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1016/j.bbadis.2025.167723
- Citations
- 2
- Primary Topic
- Neonatal and Maternal Infections
- Type
- article
- Field-Weighted Citation Impact
- 3.76
Funders
- Københavns Universitet
- China Scholarship Council
- Novo Nordisk Fonden
- Office of Defense Nuclear Nonproliferation